There's one 'very important' way to support your cognitive health.
The Well News on MSN
FDA approves labeling changes to hormone therapy products
WASHINGTON - The Food and Drug Administration has approved changes to the labeling of six hormone therapy products used to treat menopause, seeking to clarify the risks associated with them.
Menopause is linked to higher rates of anxiety, depression, and sleep disruption, along with subtle losses of gray matter in brain regions involved in emotion and memory, and hormone replacement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results